Ken Griffin’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$258M Buy
2,049,075
+1,160,047
+130% +$146M 0.04% 84
2025
Q1
$98.3M Sell
889,028
-1,649,081
-65% -$182M 0.02% 267
2024
Q4
$346M Buy
2,538,109
+773,519
+44% +$106M 0.06% 45
2024
Q3
$203M Buy
1,764,590
+1,023,651
+138% +$118M 0.04% 86
2024
Q2
$102M Sell
740,939
-100,379
-12% -$13.8M 0.02% 243
2024
Q1
$116M Buy
841,318
+729,318
+651% +$101M 0.02% 203
2023
Q4
$14.8M Sell
112,000
-624,207
-85% -$82.2M ﹤0.01% 1009
2023
Q3
$82.8M Sell
736,207
-570,066
-44% -$64.1M 0.02% 271
2023
Q2
$123M Buy
1,306,273
+831,881
+175% +$78.4M 0.03% 173
2023
Q1
$48M Buy
474,392
+288,824
+156% +$29.2M 0.01% 465
2022
Q4
$22.2M Sell
185,568
-50,078
-21% -$5.98M 0.01% 820
2022
Q3
$25M Buy
+235,646
New +$25M 0.01% 702
2022
Q2
Sell
-93,098
Closed -$8.73M 6607
2022
Q1
$8.73M Sell
93,098
-729,731
-89% -$68.4M ﹤0.01% 1527
2021
Q4
$70.1M Sell
822,829
-21,172
-3% -$1.8M 0.01% 334
2021
Q3
$80.9M Buy
844,001
+176,015
+26% +$16.9M 0.02% 265
2021
Q2
$65M Sell
667,986
-467,361
-41% -$45.5M 0.01% 385
2021
Q1
$110M Sell
1,135,347
-12,160
-1% -$1.18M 0.03% 193
2020
Q4
$110M Buy
1,147,507
+836,009
+268% +$80.1M 0.03% 192
2020
Q3
$30M Buy
311,498
+167,143
+116% +$16.1M 0.01% 582
2020
Q2
$17.6M Sell
144,355
-852,854
-86% -$104M 0.01% 803
2020
Q1
$86.3M Buy
997,209
+573,054
+135% +$49.6M 0.04% 190
2019
Q4
$45.6M Buy
424,155
+243,978
+135% +$26.2M 0.02% 453
2019
Q3
$16.2M Buy
180,177
+124,617
+224% +$11.2M 0.01% 919
2019
Q2
$4.69M Buy
55,560
+4,770
+9% +$403K ﹤0.01% 1701
2019
Q1
$4.48M Buy
+50,790
New +$4.48M ﹤0.01% 1666
2018
Q4
Sell
-439,598
Closed -$54M 4795
2018
Q3
$54M Buy
439,598
+23,431
+6% +$2.88M 0.02% 379
2018
Q2
$40.9M Buy
416,167
+97,981
+31% +$9.63M 0.02% 457
2018
Q1
$26.4M Sell
318,186
-219,221
-41% -$18.2M 0.01% 526
2017
Q4
$41.7M Buy
537,407
+320,800
+148% +$24.9M 0.03% 419
2017
Q3
$13.3M Buy
216,607
+200,055
+1,209% +$12.3M 0.01% 814
2017
Q2
$761K Sell
16,552
-961,980
-98% -$44.2M ﹤0.01% 2342
2017
Q1
$42.4M Buy
978,532
+717,664
+275% +$31.1M 0.04% 327
2016
Q4
$10.1M Sell
260,868
-776,651
-75% -$30.1M 0.01% 744
2016
Q3
$52.5M Buy
1,037,519
+103,974
+11% +$5.27M 0.05% 219
2016
Q2
$42.4M Sell
933,545
-878,118
-48% -$39.9M 0.05% 257
2016
Q1
$71.7M Buy
1,811,663
+676,839
+60% +$26.8M 0.09% 131
2015
Q4
$64.2M Buy
1,134,824
+656,626
+137% +$37.1M 0.07% 233
2015
Q3
$19M Sell
478,198
-334,286
-41% -$13.3M 0.02% 665
2015
Q2
$38.8M Buy
812,484
+419,934
+107% +$20.1M 0.03% 455
2015
Q1
$15.6M Sell
392,550
-725,676
-65% -$28.8M 0.01% 794
2014
Q4
$25M Buy
1,118,226
+182,918
+20% +$4.09M 0.02% 568
2014
Q3
$14.7M Buy
935,308
+667,174
+249% +$10.5M 0.02% 730
2014
Q2
$3.98M Buy
268,134
+224,291
+512% +$3.33M ﹤0.01% 1182
2014
Q1
$706K Buy
43,843
+3,855
+10% +$62.1K ﹤0.01% 2089
2013
Q4
$374K Buy
39,988
+37,106
+1,288% +$347K ﹤0.01% 2190
2013
Q3
$33K Sell
2,882
-13,471
-82% -$154K ﹤0.01% 2665
2013
Q2
$219K Buy
+16,353
New +$219K ﹤0.01% 2227